Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kálmán Harsányi & István Szabadkai. (1992) Overview: Recent Developments in Anti-ulcer Agents. Current Opinion on Therapeutic Patents 2:4, pages 385-399.
Read now
Read now
. (1990) References. Scandinavian Journal of Gastroenterology 25:sup177, pages 99-103.
Read now
Read now
Articles from other publishers (10)
Cesar J Garcia, Juan Castro-Combs, Ajoy Dias, Rodrigo Alfaro, Javier Vasallo, Marek Majewski, Tom Jaworski, Grzegorz Wallner & Jerzy Sarosiek. (2013) Impairment of Salivary Mucin Production Resulting in Declined Salivary Viscosity During Naproxen Administration as a Potential Link to Upper Alimentary Tract Mucosal Injury. Clinical and Translational Gastroenterology 4:7, pages e40.
Crossref
Crossref
T. Jaworski, I. Sarosiek, S. Sostarich, K. Roeser, M. Connor, S. Brotze, G. Wallner & J. Sarosiek. (2005) Restorative Impact of Rabeprazole on Gastric Mucus and Mucin Production Impairment During Naproxen Administration: Its Potential Clinical Significance. Digestive Diseases and Sciences 50:2, pages 357-365.
Crossref
Crossref
Kent-Man Chu. (2005)
Patients with
Helicobacter pylori
positive and negative duodenal ulcers have distinct clinical characteristics
. World Journal of Gastroenterology 11:23, pages 3518.
Crossref
Crossref
Nancy Fox Ray, Mae Thamer & Scott C. Henderson. (1998) Adoption of New Pharmacotherapeutic Regimens: Analysis of Physician Prescribing for Peptic Ulcer Disease. Drug Information Journal 32:4, pages 1119-1131.
Crossref
Crossref
&NA; Thamer, Nancy Fox Ray, Scott C. Henderson, Cheryl S. Rinehart, Charles R. Sherman & John H. Ferguson. (1998) Influence of the NIH Consensus Conference on Helicobacter Pylori on Physician Prescribing Among a Medicaid Population. Medical Care 36:5, pages 646-660.
Crossref
Crossref
Martin J. Collen & Richard M. Strong. (1993) Helicobacter pylori in duodenal ulcer patients with idiopathic gastric acid hypersecretion. Digestive Diseases and Sciences 38:1, pages 132-136.
Crossref
Crossref
M. V. Agrez, D. A. Henry, S. Senthiselvan & J. M. Duggan. (2010) CHANGING TRENDS IN PERFORATED PEPTIC ULCER DURING THE PAST 45 YEARS. Australian and New Zealand Journal of Surgery 62:9, pages 729-732.
Crossref
Crossref
KWOK‐HUNG LAI, FULL‐YOUNG CHANG, SHYH‐HAW TSAY, LEE‐CHENG LU, JIUNN‐TARNG CHENG, SHENG‐SHONG JENG, TZEE‐CHUNG WU, WAI‐WAH NG, JIN‐SHIUNG JENG, SHOU‐DONG LEE & YANG‐TE TSAI. (2008)
Medical treatment of duodenal ulcer: Acid inhibition or
Helicobacter pylori
eradication?
. Journal of Gastroenterology and Hepatology 6:2, pages 141-144.
Crossref
Crossref
T. M. SHALLCROSS, B. J. RATHBONE, J. I. WYATT & R. V. HEATLEY. (2007) Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs. Alimentary Pharmacology & Therapeutics 4:5, pages 515-522.
Crossref
Crossref
J. C. Debongnie. (1990) La gastrite type B: une gastrite bactérienne: réalité ou fantaisie ?Type B gastritis is bacterial gastritis: fact or fancy ?La gastritis tipo B: una gastritis bacteriana: realidad o ficcion ?. Acta Endoscopica 20:4, pages 415-425.
Crossref
Crossref